The Associations Between Gut Length, Gut Microbiota and Food Assimilation

Associations Between Gut Length, Gut Microbiota and Food Assimilation Efficiency of Healthy Individuals

The purpose of this observational study is to explore the relationships between gut length, the microbiota and food energy assimilation rates in humans.

Study Overview

Detailed Description

The focus of this work is to characterize the relationship between gut length, gut microbiota and food energy assimilation rate in healthy individuals.

The gut will be scanned using Magnetic Resonance Imaging (MRI) to calculate gut length. To obtain clearer images, volunteers will be asked to drink 1/1.5 sachet of He Shuang (polyethylene glycol electrolyte powder, molecular weight of 4000) and injected Raceanisodamine Hydrochloride Injection with 10 mg by intramuscular. Volunteers will be asked to drink He Shuang, which dissolved in 1/1.5L of water for the purpose of filling the intestines. As a contrast to improve imaging during scanning.

Volunteers will be given the experimental meal, which providing enough energy for volunteers to eat as much as they want. Feces and urine will be collected to calculate the assimilation rate. To more accurately label the food, edible polyethylene glycol with a molecular weight of 3350(PEG3350) is used. Provides 1.5g of PEG3350 per day, to be used with meals. PEG3350 reaches a steady state in the intestinal tract for 3 days. Food will be provided for seven days during the test period, the first three days are aimed at stabilizing the PEG3350 in the intestine, and the samples to be counted are mainly collected in the last four days. Food assimilation rate and metabolizable energy will be calculated for the 4-day.

The gut microbiota will be analyzed by metagenomics and metabolomics. This study combines metabolomics analysis techniques with imaging and physiological measurements to focus on the potential relationship between gut length and food absorption rates. Researchers anticipate recruiting up to 100 healthy volunteers (body mass index ≥ 18.5).

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China, 518055
        • Shenzhen Institute of Advanced Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

100 individuals, 50 female and 50 male

Description

Inclusion Criteria:

  • Age between 18-40 years old, healthy and disease free.
  • Regular bowel movements.

Exclusion Criteria:

  • Individuals who are constipated or suffer from intestinal disorders;
  • Individuals with mental illnesses such as depression and claustrophobia;
  • Individuals with glaucoma and prostate hypertrophy;
  • Metal implants in the body;
  • Pregnant and lactating women;
  • Individuals with blood phobia, pathologic hypotension or hypertension;
  • Use of antibiotics, probiotics, oral laxatives within 8 weeks;
  • Individuals with metabolic diseases (e.g., chronic diseases such as diabetes mellitus); recent weight loss due to various medical reasons;
  • Individuals with infectious diseases (e.g. HIV);
  • Irregular diet, lifestyle, addiction to tobacco, alcohol or drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Age between 18-40 years old, 100subjects(50 female and 50 man)

He Shuang(Polyethylene Glycol Electrolytes Powder):1/1.5 sachets of PEG(68.56-102.84g dissolved in water with1/1.5L ) were provided to volunteers based on body weight(BW): BW<60 kg, 1 sachet , BW≥60 kg, 1.5 sachets, drinking an average of 200/250 mL every 15 minutes. It will cause frequent bowel motions or diarrhoea for a couple of hours afterwards.

Raceanisodamine Hydrochloride Injection: intramuscular injection of Raceanisodamine Hydrochloride Injection with 10mg. It may cause dry mouth, red face and blurred vision. The half-life of the medicine is 40 minutes and most of the above symptoms disappear within 1 to 3 hours.

Observation of gut length, food intake, fecal and urine calories, body composition, microbiota, metabolic rate, metabolomics.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy intake
Time Frame: Through study completion for one year, will be measured on arrival.
Response on standard feeding table, the food consumption will be recorded continuously by balances underneath each food dish. The total energy intake will be calculated in KJ (kilojoule).
Through study completion for one year, will be measured on arrival.
Metabolites
Time Frame: Through study completion for one year, will be measured on arrival.
Abundance of metabolites will be from metabolomic profiling of feces by LC-MS (liquid chromatography mass spectrometry).
Through study completion for one year, will be measured on arrival.
Gut length
Time Frame: Through study completion for one year, will be measured on arrival.
Volunteers will be scanned Magnetic Resonance Imaging(Shanghai united imaging, uMR 790).
Through study completion for one year, will be measured on arrival.
Fecal energy
Time Frame: Through study completion for one year, will be measured on arrival
Measuring the heat produced by burning dried feces using an oxygen bomb calorimeter (Parr6400). The total energy per gram tissue will be calculated in kJ (kilojoule)/g.
Through study completion for one year, will be measured on arrival
Microbiome/Microbiota
Time Frame: Through study completion for one year, will be measured on arrival.
Abundance of gut microbiome will be from Metagenomic profiling of feces by Illumina.
Through study completion for one year, will be measured on arrival.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Through study completion for one year, will be measured on arrival.
Height will be measured by seca 217 stable stadiometer.
Through study completion for one year, will be measured on arrival.
Waist circumferences
Time Frame: Through study completion for one year, will be measured on arrival.
Waist circumferences will be measured using a whole body laser scanner(TG2000-F).
Through study completion for one year, will be measured on arrival.
Hip circumferences
Time Frame: Through study completion for one year, will be measured on arrival.
Hip circumferences will be measured using a whole body laser scanner(TG2000-F).
Through study completion for one year, will be measured on arrival.
Bone mass
Time Frame: Through study completion for one year, will be measured on arrival.
Bone mass will be measured by Dual Energy X-ray Absorptiometry (Horizon Wi).
Through study completion for one year, will be measured on arrival.
Fat mass
Time Frame: Through study completion for one year, will be measured on arrival.
Fat mass will be measured by Magnetic Resonance Imaging (Shanghai united imaging, uMR 790 ) and BOD POD(COS MED,BOD POD 2020).
Through study completion for one year, will be measured on arrival.
Fat free mass
Time Frame: Through study completion for one year, will be measured on arrival.
Fat free mass will be measured by Bioimpedance Analysis (Tanita, MC-980) and BOD POD(COS MED,BOD POD 2020).
Through study completion for one year, will be measured on arrival.
Blood pressure
Time Frame: Through study completion for one year, will be measured on arrival.
Systolic and diastolic blood pressure will be measured using an Omron sphygmomanometer.
Through study completion for one year, will be measured on arrival.
Heart rate
Time Frame: Through study completion for one year, will be measured on arrival.
Heart rate will be measured using an Omron sphygmomanometer.
Through study completion for one year, will be measured on arrival.
Resting energy expenditure
Time Frame: Through study completion for one year, will be measured on arrival.
The measurement of resting energy expenditure will be performed using indirect calorimetry(Whole room calorimetry) for 24h.
Through study completion for one year, will be measured on arrival.
Thermic effect of food
Time Frame: Through study completion for one year, will be measured on arrival.
The measurement of resting energy expenditure will be performed using indirect calorimetry(Whole room calorimetry) for 24h.
Through study completion for one year, will be measured on arrival.
Body shape
Time Frame: Through study completion for one year, will be measured on arrival.
Body shape will be measured using a whole body laser scanner(TG2000-F)
Through study completion for one year, will be measured on arrival.
Food macronutrient content
Time Frame: Through study completion for one year, will be measured on arrival.
Detection of carbohydrates, proteins and fats in food by chemical analysis.
Through study completion for one year, will be measured on arrival.
Feces macronutrient content
Time Frame: Through study completion for one year, will be measured on arrival.
Detection of carbohydrates, proteins and fats in feces by chemical analysis.
Through study completion for one year, will be measured on arrival.
Total daily water volume
Time Frame: Through study completion for one year, will be measured on arrival.
Calculate the total amount of water to be consumed in a day by providing water cups with a graduated scale.
Through study completion for one year, will be measured on arrival.
Total daily urine volume
Time Frame: Through study completion for one year, will be measured on arrival.
Collect the urine sample within a day in a graduated container.
Through study completion for one year, will be measured on arrival.
Physical activity
Time Frame: Through study completion for one year, will be measured on arrival.
Physical activity of the participants will be recorded using GT3X accelerometer worn near the hip for a consecutive period of 7 days. The monitor should not be worn while bathing or swimming. The first day is discarded along with any day where the wear time is less than 12 hours. For a valid measure the goal is to get 2 weekday and 2 weekend days.
Through study completion for one year, will be measured on arrival.
Urine energy content
Time Frame: Through study completion for one year, will be measured on arrival.
Energy content will be evaluated by measuring the heat energy produced when burning dried urine using an oxygen bomb calorimeter (Parr6400). The total energy per gram tissue will be calculated in kJ (kilojoule)/g.
Through study completion for one year, will be measured on arrival.
Body weight
Time Frame: Through study completion for one year, will be measured on arrival.
Volunteers will be asked to fast for 10 hours and measured fasting weight.
Through study completion for one year, will be measured on arrival.
Bristol Stool Scale
Time Frame: Through study completion for one year, will be measured on arrival.
Scoring of stool forms according to the Bristol Stool Scale, whice classified according to faecal characteristics. It has seven types. Types 1 and 2 indicate the presence of constipation, types 3 and 4 are ideal stool shapes, and types 5 to 7 represent possible diarrhoea.
Through study completion for one year, will be measured on arrival.
Gut transit time
Time Frame: Through study completion for one year, will be measured on arrival.
Recording the time of intake of food-grade blue pigment and the time of excretion
Through study completion for one year, will be measured on arrival.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: John R Speakman, PhD, Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2024

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

April 17, 2024

First Submitted That Met QC Criteria

April 17, 2024

First Posted (Actual)

April 22, 2024

Study Record Updates

Last Update Posted (Actual)

January 22, 2026

Last Update Submitted That Met QC Criteria

January 19, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Food Preferences

Clinical Trials on Observation without intervention

Subscribe